TrialThe journal of headache and pain2020
A prospective real-world analysis of erenumab in refractory chronic migraine.
Giorgio Lambru et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
102 papers cite itlatest 60 shown
this paperpooled ittrialcites it